The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Julia S. Johansen

Department of Oncology

Herlev Hospital

Copenhagen University Hospital

University of Copenhagen

Denmark

[email]@*.tele.dk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Oncology, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Denmark. 2000 - 2010
  • Department of Rheumatology, Herlev Hospital, Denmark. 2004 - 2008
  • Connective Tissue Laboratory, Department of Rheumatology, H:S Hvidovre Hospital, Denmark. 2003

References

  1. Plasma YKL-40 and total and disease-specific mortality in the general population. Johansen, J.S., Bojesen, S.E., Tybjaerg-Hansen, A., Mylin, A.K., Price, P.A., Nordestgaard, B.G. Clin. Chem. (2010) [Pubmed]
  2. Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population. Johansen, J.S., Bojesen, S.E., Mylin, A.K., Frikke-Schmidt, R., Price, P.A., Nordestgaard, B.G. J. Clin. Oncol. (2009) [Pubmed]
  3. Plasma YKL-40: a potential new cancer biomarker?. Johansen, J.S., Schultz, N.A., Jensen, B.V. Future. Oncology. (london,. England) (2009) [Pubmed]
  4. High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality. Johansen, J.S., Pedersen, A.N., Schroll, M., Jørgensen, T., Pedersen, B.K., Bruunsgaard, H. Clin. Exp. Immunol. (2008) [Pubmed]
  5. Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects. Johansen, J.S., Lottenburger, T., Nielsen, H.J., Jensen, J.E., Svendsen, M.N., Kollerup, G., Christensen, I.J. Cancer Epidemiol. Biomarkers Prev. (2008) [Pubmed]
  6. Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival. Johansen, J.S., Brasso, K., Iversen, P., Teisner, B., Garnero, P., Price, P.A., Christensen, I.J. Clin. Cancer Res. (2007) [Pubmed]
  7. YKL-40 protein expression in the early developing human musculoskeletal system. Johansen, J.S., Høyer, P.E., Larsen, L.A., Price, P.A., Møllgård, K. J. Histochem. Cytochem. (2007) [Pubmed]
  8. Is YKL-40 a new therapeutic target in cancer?. Johansen, J.S., Jensen, B.V., Roslind, A., Price, P.A. Expert Opin. Ther. Targets (2007) [Pubmed]
  9. Serum YKL-40, a new prognostic biomarker in cancer patients?. Johansen, J.S., Jensen, B.V., Roslind, A., Nielsen, D., Price, P.A. Cancer Epidemiol. Biomarkers Prev. (2006) [Pubmed]
  10. Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity?. Johansen, J.S., Milman, N., Hansen, M., Garbarsch, C., Price, P.A., Graudal, N. Respir. Med (2005) [Pubmed]
  11. Circulating YKL-40 levels during human endotoxaemia. Johansen, J.S., Krabbe, K.S., Møller, K., Pedersen, B.K. Clin. Exp. Immunol. (2005) [Pubmed]
  12. High serum YKL-40 level in patients with small cell lung cancer is related to early death. Johansen, J.S., Drivsholm, L., Price, P.A., Christensen, I.J. Lung. Cancer (2004) [Pubmed]
  13. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Johansen, J.S., Christensen, I.J., Riisbro, R., Greenall, M., Han, C., Price, P.A., Smith, K., Brünner, N., Harris, A.L. Breast Cancer Res. Treat. (2003) [Pubmed]
  14. Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction. Johansen, J.S., Kirwan, J.R., Price, P.A., Sharif, M. Scand. J. Rheumatol. (2001) [Pubmed]
  15. Serum YKL-40 is increased in patients with hepatic fibrosis. Johansen, J.S., Christoffersen, P., Møller, S., Price, P.A., Henriksen, J.H., Garbarsch, C., Bendtsen, F. J. Hepatol. (2000) [Pubmed]
 
WikiGenes - Universities